Laszlo Garamszegi - Aurora Spine CTO Founder
| ASAPF Stock | USD 0.23 0.03 15.00% |
Insider
Laszlo Garamszegi is CTO Founder of Aurora Spine
| Age | 52 |
| Phone | 760 424 2004 |
| Web | https://www.aurora-spine.com |
Aurora Spine Management Efficiency
The company has return on total asset (ROA) of (0.0851) % which means that it has lost $0.0851 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2737) %, meaning that it generated substantial loss on money invested by shareholders. Aurora Spine's management efficiency ratios could be used to measure how well Aurora Spine manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Hector Martinez | BICO Group AB | 38 | |
| Erica Bell | Cellink AB | 50 | |
| Farid Anthony | Brain Scientific | 41 | |
| Richard Ginn | Tenon Medical | 59 | |
| Kevin Winterfield | Brain Scientific | N/A | |
| Erik Gatenholm | BICO Group AB | 34 | |
| Lotta Bus | Cellink AB | 53 | |
| Vadim Sakharov | Brain Scientific | 49 | |
| Irina Nazarova | Brain Scientific | N/A | |
| Artur Aira | BICO Group AB | 56 | |
| Itedale Redwan | BICO Group AB | N/A | |
| Stuart Bernstein | Brain Scientific | N/A | |
| Erik Gatenholm | Cellink AB | 34 | |
| Mark Broderick | Brain Scientific | N/A | |
| Asa Hillsten | Cellink AB | 48 | |
| Karin Danielsson | BICO Group AB | 41 | |
| Niclas Emanuelsson | Cellink AB | 52 | |
| Lotta Bus | BICO Group AB | 53 | |
| Asa Hillsten | BICO Group AB | 48 | |
| BonnieJeanne Gerety | Brain Scientific | 61 | |
| HuiLan Wu | Ainos Inc | 63 | |
Management Performance
| Return On Equity | -0.27 | |||
| Return On Asset | -0.0851 |
Aurora Spine Leadership Team
Elected by the shareholders, the Aurora Spine's board of directors comprises two types of representatives: Aurora Spine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aurora. The board's role is to monitor Aurora Spine's management team and ensure that shareholders' interests are well served. Aurora Spine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aurora Spine's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Trent Northcutt, President, Founder | ||
| David Meyer, Chief VP | ||
| Laszlo Garamszegi, CTO Founder | ||
| Chad Clouse, Chief Officer |
Aurora Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Aurora Spine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.27 | |||
| Return On Asset | -0.0851 | |||
| Profit Margin | (0.11) % | |||
| Operating Margin | (0.10) % | |||
| Current Valuation | 25.13 M | |||
| Shares Outstanding | 66.73 M | |||
| Shares Owned By Insiders | 17.89 % | |||
| Price To Book | 4.22 X | |||
| Price To Sales | 1.70 X | |||
| Revenue | 10.54 M |
Currently Active Assets on Macroaxis
Other Information on Investing in Aurora OTC Stock
Aurora Spine financial ratios help investors to determine whether Aurora OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aurora with respect to the benefits of owning Aurora Spine security.